My approach to and thoughts on the typing of ovarian carcinomas

被引:103
作者
McCluggage, W. G. [1 ]
机构
[1] Royal Grp Hosp Trust, Dept Pathophysiol, Belfast BT12 6BL, Antrim, North Ireland
关键词
D O I
10.1136/jcp.2007.049478
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Ovarian carcinomas of epithelial type comprise a heterogeneous group of neoplasms, each with a different underlying pathogenesis and natural behaviour. Accurate classification of ovarian carcinomas is important since each type may be associated with a different behaviour, natural history and outcome. Precise classification is also critical to determine whether alternative therapeutic strategies are appropriate for different tumour types. Previous studies have shown significant interobserver variation in the typing of ovarian carcinomas. There are several areas where there are particular difficulties; these include the distinction between high-grade serous and endometrioid adenocarcinomas and the distinction between a true clear cell carcinoma and clear cell areas within other adenocarcinomas. This review details my approach to the typing of ovarian carcinomas. Morphological assessment, which remains the mainstay in diagnosis, can be supplemented by immunohistochemistry which, for example, is useful in the distinction between serous carcinomas ( WT1 positive) and other carcinomas ( generally WT1 negative). In recent years, there has been emerging new information regarding the major underlying molecular events in several types of ovarian carcinoma. This has resulted in the acceptance that there are two distinct types of ovarian serous carcinoma. These are termed low-grade and high-grade serous carcinoma, but represent two distinct tumour types rather than low-grade and high-grade variants of the same neoplasm. The integration of clinical, morphological and molecular data has resulted in a more precise classification of ovarian carcinomas and has resulted in the proposal for a broad dualistic pathway of ovarian epithelial carcinogenesis with, in general, low-grade type 1 tumours evolving from benign and borderline neoplasms through a well-defined adenoma-carcinoma sequence, and high-grade type 2 neoplasms arising from an, as yet, undefined precursor lesion.
引用
收藏
页码:152 / 163
页数:12
相关论文
共 93 条
  • [1] WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma
    Al-Hussaini, M
    Stockman, A
    Foster, H
    McCluggage, WG
    [J]. HISTOPATHOLOGY, 2004, 44 (02) : 109 - 115
  • [2] BAAK JPA, 1986, ANAL QUANT CYTOL, V8, P354
  • [3] A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary
    Bell, KA
    Kurman, RJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (11) : 1465 - 1479
  • [4] BEREZOWSKI K, 1996, MODERN PATHOL, V9, P1040
  • [5] REPRODUCIBILITY AND PROGNOSTIC VALUE OF HISTOLOGIC TYPE AND GRADE IN EARLY EPITHELIAL OVARIAN-CANCER
    BERTELSEN, K
    HOLUND, B
    ANDERSEN, E
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (02) : 72 - 79
  • [6] FURTHER EVALUATION OF REPRODUCIBILITY AND PROGNOSTIC VALUE OF HISTOLOGIC TYPING AND GRADING IN FIGO STAGE-I OVARIAN-CANCER PATIENTS WITHOUT SYSTEMIC LOCOREGIONAL ADJUVANT TREATMENT
    BRUGGHE, J
    BAAK, JPA
    WILTSHAW, E
    FISHER, C
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (04) : 262 - 268
  • [7] A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma
    Cameron, RI
    Ashe, P
    O'Rourke, DM
    Foster, H
    McCluggage, WG
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2003, 22 (03) : 272 - 276
  • [8] CANTRECASAS M, 1997, CANCER, V70, P1581
  • [9] Molecular genetic alterations in endometrioid carcinomas of the ovary:: Similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas
    Catasús, L
    Bussaglia, E
    Rodríguez, I
    Gallardo, A
    Pons, C
    Irving, JA
    Prat, J
    [J]. HUMAN PATHOLOGY, 2004, 35 (11) : 1360 - 1368
  • [10] Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms
    Cho, EY
    Choi, Y
    Chae, SW
    Sohn, JH
    Ahn, GH
    [J]. PATHOLOGY INTERNATIONAL, 2006, 56 (02) : 62 - 70